AbrahamSMozhiNMJosephGAEpidemiological significance of first skin lesion in leprosyInt J Lepr Other Mycobact Dis199866131139
2.
ArvieuxJRenaudineauYManeIDistinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndromeThromb Haemost200287599605
3.
Azulay-AbulafiaLPereira SpinelliLHardmannDLucio phenomenon. Vasculitis or occlusive vasculopathy?Hautarzt2006571101110510.1007/s00105-005-1086-3
4.
BaezaILepromatous leprosy patients produce antibodies that recognize non-biliary lipid arrangements containing mycolic acidsMem Inst Oswaldo Cruz201219510310.1590/S0074-02762012000900016
5.
BekriWGebreSMengisteASaundersonPRZewgeSDelay in presentation and start of treatment in leprosy patients: A case–control study of disabled and non-disabled patients in three different settings in EthiopiaInt J Lepr Other Mycobact Dis19986619
6.
BrochadoMJNascimentoMMLouzada JuniorPFigueiredoJFRoselinoAMVal247Leu polymorphism of beta2 glycoprotein 1 gene may justify the genesis of anti beta2GP1 antibodies and antiphospholipid syndrome in multibacillary leprosyAn Bras Dermatol20098435535910.1590/S0365-05962009000400006
7.
de LarrañagaGFForastieroRRMartinuzzoMEHigh prevalence of antiphospholipid antibodies in leprosy: Evaluation of antigen reactivityLupus2000959460010.1191/096120300678828712
8.
ElbeialyAStrassburger-LornaKAtsumiTAntiphospholipid antibodies in leprotic patients: A correlation with disease manifestationsClin Exp Rheumatol200018492494
9.
ForastieroRRMartinuzzoMEde LarrañagaGFCirculating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodiesLupus20051412913610.1191/0961203305lu2048oa
10.
GalliMComfuriusPMaassenCAnticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorLancet19903351544154710.1016/0140-6736(90)91374-J
11.
GilburdBZiporenLZharharyDAntimitochondrial (pyruvate dehydrogenase) antibodies in leprosyJ Clin Immunol199414141910.1007/BF01541171
12.
Guedes BarbosaLSGilbrutBShoenfeldYScheinbergMAAutoantibodies in leprosy seraClin Rheumatol199615262810.1007/BF02231680
13.
HojnikMGilburdBZiporenLAnticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: Analysis of anticardiolipin antibodies in leprosyLupus1994351552110.1177/096120339400300615
14.
IyerAHattaMUsmanRSerum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactionsClin Exp Immunol200715021021610.1111/j.1365-2249.2007.03485.x2219358
15.
LevyRAde MeisEPierangeliSAn adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assayThromb Res200411457357710.1016/j.thromres.2004.06.032
16.
MartinuzzoMEForastieroRRCarrerasLOAnti beta 2 glycoprotein I antibodies: Detection and association with thrombosisBr J Haematol19958939740210.1111/j.1365-2141.1995.tb03317.x
17.
MatsuoELeprosy as a challenge to science on the ability to decode its enigma. A hypothesis on how to respondJpn J Infect Dis2005585964
18.
McNallyTPurdyGMachieIJThe use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosisBr J Haematol19959147147310.1111/j.1365-2141.1995.tb05324.x
19.
MurthyPKCurrent epidemiology of leprosyJ Indian Med Assoc2004102672683
20.
PalumboACavoMBringhenSAspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: A phase III, open-label, randomized trialJ Clin Oncol20112998699310.1200/JCO.2010.31.6844
SharmaNLSharmaVCMahajanVKThalidomide: An experience in therapeutic outcome and adverse reactionsJ Dermatol Treat20071833534010.1080/09546630701386993
23.
Teixeira JuniorGJSilvaCEMagalhãesVApplication of the diagnostic criteria for systemic lupus erythematosus to patients with multibacillary leprosyRev Soc Bras Med Trop201144859010.1590/S0037-86822011000100019
24.
Vargas-OcampoFDiffuse leprosy of Lucio and Latapí: A histologic studyLepr Rev200778248260
